Searched for
APALUTAMIDE
Johnson & Johnson prostate cancer drug reduces risk of cancer spread and death in late-stage studyThe study, which followed patients for over five years, found that those who received the regimen were nine times more likely to have lit...- Zydus Lifesciences shares rally 3% after FDA approval for prostate cancer drugZydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last week's approval for...
- Stocks in news: Bajaj Auto, L&T, Bharti Airtel, Hindustan Zinc, Dr Reddy’sZydus Lifesciences said it has received final approval from the US health regulator to manufacture a generic version of Apalutamide tablets...
- Zydus Lifesciences gets USFDA nod to produce prostate cancer treatment drugZydus Lifesciences Ltd has received final approval from the USFDA to manufacture 60 mg Apalutamide tablets for prostate cancer treatment. T...
- BDR Pharmaceutical launches generic drug for treating prostate cancer in IndiaBDR Group Director Business Development Raheel Shah said that the launch of APATIDE is "testimony towards our commitment in providing acces...
Load More